Latest filing published 15 Oct 2021 for Cognition Therapeutics INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Mark H. Breedlove: trading record in brief
Mark H. Breedlove (board member) discloses dealings in Cognition Therapeutics Inc to SEC (Form 4). The record holds 6 filings, all for trades on 13 October 2021.
The open-market record consists of 1 sale worth €121, with no purchase.
The record was last updated on 15 October 2021 with a transaction (€120) in Cognition Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark H. Breedlove
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 44,806 sharesCommon StockSEC:0001104659-21-126894:0
1 of 1 declaration
